Nirogi, R., Abraham, R., Jayarajan, P., Goura, V., Kallepalli, R., Medapati, R. b., . . . Jasti, V. (2022). Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: Pharmacological, behavioral, and neurochemical characterization. Psychopharmacology, 239(7), 2215-2233.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Nirogi, Ramakrishna, et al. "Ropanicant (SUVN-911), an α4β2 Nicotinic Acetylcholine Receptor Antagonist Intended for the Treatment of Depressive Disorders: Pharmacological, Behavioral, and Neurochemical Characterization."
Psychopharmacology 239, no. 7 (2022): 2215-2233.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Nirogi, Ramakrishna, et al. "Ropanicant (SUVN-911), an α4β2 Nicotinic Acetylcholine Receptor Antagonist Intended for the Treatment of Depressive Disorders: Pharmacological, Behavioral, and Neurochemical Characterization."
Psychopharmacology, vol. 239, no. 7, 2022, pp. 2215-2233.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.